Overview

Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in Thrombosis

Status:
Completed
Trial end date:
2001-01-01
Target enrollment:
Participant gender:
Summary
To perform a randomized clinical trial comparing continuing one month of treatment with heparin in patients with deep venous thrombosis to standard care using heparin for five days and oral warfarin for three months.
Details
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Heparin
Warfarin